Literature DB >> 10814697

Characterization of the interaction between galectin-1 and lymphocyte glycoproteins CD45 and Thy-1.

A Symons1, D N Cooper, A N Barclay.   

Abstract

Galectin-1 is a sugar binding protein specific for beta-galactosides and not requiring metal ions for binding activity. It exists as a soluble protein which forms a noncovalent homodimer and is expressed with a broad tissue distribution. Recently, galectin-1 has been shown to play a possible role in the immune system mediating apoptosis of activated T cells with indirect evidence suggesting that galectin-1 interacts with the heavily glycosylated, transmembrane, protein phosphotyrosine phosphatase CD45. The interaction of galectin-1 with purified lymphocyte cell surface proteins was studied using surface plasmon resonance in a BIAcoretrade mark. Galectin-1 was shown to bind CD45 and Thy-1 in a carbohydrate-dependent manner. Several galectin-1 molecules could bind each CD45 molecule. The dissociation constant of dimeric galectin-1 binding to CD45 was measured at approximately 5 microM, indicating the concentration at which cross-linking of cell surface glycoproteins by galectin-1 would occur. A possible role for galectin-1 in the organization of cell surface glycoproteins is discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10814697     DOI: 10.1093/glycob/10.6.559

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  8 in total

Review 1.  CD45: all is not yet crystal clear.

Authors:  Nick Holmes
Journal:  Immunology       Date:  2006-02       Impact factor: 7.397

Review 2.  Receptor-type tyrosine phosphatase ligands: looking for the needle in the haystack.

Authors:  Alma N Mohebiany; Roman M Nikolaienko; Samuel Bouyain; Sheila Harroch
Journal:  FEBS J       Date:  2012-07-05       Impact factor: 5.542

3.  A high-frequency polymorphism in exon 6 of the CD45 tyrosine phosphatase gene (PTPRC) resulting in altered isoform expression.

Authors:  Tara Stanton; Sally Boxall; Kouzo Hirai; Ritu Dawes; Susan Tonks; Tomoyo Yasui; Yasushi Kanaoka; Nadira Yuldasheva; Osamu Ishiko; Walter Bodmer; Peter C L Beverley; Elma Z Tchilian
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-25       Impact factor: 11.205

4.  Molecular dynamics simulations of galectin-1-oligosaccharide complexes reveal the molecular basis for ligand diversity.

Authors:  Michael G Ford; Thomas Weimar; Thies Köhli; Robert J Woods
Journal:  Proteins       Date:  2003-11-01

5.  Combinations of CD45 isoforms are crucial for immune function and disease.

Authors:  Ritu Dawes; Svetla Petrova; Zhe Liu; David Wraith; Peter C L Beverley; Elma Z Tchilian
Journal:  J Immunol       Date:  2006-03-15       Impact factor: 5.422

Review 6.  Viral interference with functions of the cellular receptor tyrosine phosphatase CD45.

Authors:  Nadine Thiel; Jasmin Zischke; Endrit Elbasani; Penelope Kay-Fedorov; Martin Messerle
Journal:  Viruses       Date:  2015-03-23       Impact factor: 5.048

7.  Galectin-9 binds IgM-BCR to regulate B cell signaling.

Authors:  Anh Cao; Nouf Alluqmani; Fatima Hifza Mohammed Buhari; Laabiah Wasim; Logan K Smith; Andrew T Quaile; Michael Shannon; Zaki Hakim; Hossai Furmli; Dylan M Owen; Alexei Savchenko; Bebhinn Treanor
Journal:  Nat Commun       Date:  2018-08-17       Impact factor: 14.919

8.  Thy-1 (CD90) Signaling Preferentially Promotes RORγt Expression and a Th17 Response.

Authors:  Suzanne Furlong; Melanie R Power Coombs; Javad Ghassemi-Rad; David W Hoskin
Journal:  Front Cell Dev Biol       Date:  2018-11-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.